Page last updated: 2024-12-07

5-hydroxyuridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Hydroxyuridine (5-OHU) is a nucleoside analog of uridine. It is a naturally occurring compound found in various organisms. It has been shown to exhibit a range of biological activities, including anti-inflammatory, antiviral, and anticancer effects. 5-OHU is formed by the enzymatic oxidation of uridine through the action of uridine 5'-monophosphate dehydrogenase (UMPH). This reaction is critical in regulating the levels of uridine nucleotides and the synthesis of RNA. 5-OHU has been investigated as a potential therapeutic agent due to its ability to inhibit viral replication, reduce inflammation, and promote apoptosis in cancer cells. Research has shown that 5-OHU can interact with specific proteins and enzymes involved in cell signaling and immune responses. The mechanism of action of 5-OHU involves modulation of various cellular pathways, including the activation of adenosine monophosphate-activated protein kinase (AMPK) and the inhibition of nuclear factor kappa B (NF-κB) signaling. Its potential in the development of new drugs for a variety of diseases continues to be explored.'

5-hydroxyuridine : A member of the class of uridines that is uridine in which the hydrogen at position 5 of the uracil ring is substituted by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID94196
CHEBI ID149645
SCHEMBL ID451947
MeSH IDM0055521

Synonyms (21)

Synonym
1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-hydroxy-pyrimidine-2,4-dione
5-oxouridine
5-hydroxyuridine
2,4(1h,3h)-pyrimidinedione, 5-hydroxy-1-.beta.-d-ribofuranosyl-
957-77-7
isobarbituridine
1-(beta-d-ribofuranosyl)-5-hydroxypyrimidine-2,4(1h,3h)-dione
CHEBI:149645
1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxypyrimidine-2,4-dione
4,5-dihydroxy-1-pentofuranosylpyrimidin-2(1h)-one
einecs 213-487-1
SCHEMBL451947
1-((2s,3s,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-hydroxypyrimidine-2,4(1h,3h)-dione;st082427
1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-hydroxypyrimidine-2,4(1h,3h)-dione
uridine, 5-hydroxy-
c9h12n2o7
mfcd00010571
DTXSID60914856
F12676
ohurd
A848611

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" All three tumor cell lines were more sensitive to OHUrd than were the FeInt cells, whereas 5-FU was more toxic to the latter."( Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
Giovanella, BC; Lockshin, A; Mendoza, JT; Stehlin, JS; Warneke, C,
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
uridines
organic hydroxy compoundAn organic compound having at least one hydroxy group attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (33.33)18.7374
1990's3 (20.00)18.2507
2000's1 (6.67)29.6817
2010's5 (33.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.32 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]